LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. SPY
2. USO
3. IONQ
4. IONS
5. ACN
6. AZN
7. ROIV
8. AAPL
9. QCOM
10. NVDA

Go back to LEXICON PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES A BUSINESS UPDATE

Lexicon Pharma (LXRX) Tops Q1 EPS by 6c, Slight Beat on Revenues

April 27, 2020 7:02 AM EDT

Lexicon Pharma (NASDAQ: LXRX) reported Q1 EPS of ($0.63), $0.06 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $7.88 million versus the consensus estimate of $7.79 million.

We achieved 17% growth in XERMELO net sales for the first quarter of 2020 compared to the... More